News

RWD/RWE In Focus: Key trends at the IPhEB forum

2026-04-13 16:54
At the XVI International Forum for Pharmaceuticals and Biotechnology held in St Petersburg, the crucial role of Real-World Data (RWD) and Real-World Evidence (RWE) in the pharmaceutical industry was highlighted.

Daria Bychkova, Director of Strategic Partnerships for Medical Affairs and Ethics at the AIPM, emphasized the transformative power of these tools.
"RWD/RWE are becoming a key tool of modern pharmaceuticals, which allows not only to control the safety and effectiveness of therapy in real conditions, but also to significantly optimize the use of budget funds. It is especially important that these technologies help to implement the principles of personalized medicine and value-based healthcare. AIPM is actively developing this area, raising awareness of specialists about the role of RWE in modern medicine, increasing expertise within the industry, and improving the regulatory framework," emphasized Daria Bychkova.
Key areas of focus for RWE development include:
  • Strengthening regulatory frameworks in Russia and the EAEU
  • Building robust data infrastructure, such as registries and electronic medical records
  • Training qualified specialists
  • Integrating Russian research into global practices

The forum also featured contributions from the AIPM working group, including:
  • Alexey Alexandrovich Yunin, Head of the Medical Department for Healthcare Professionals at Eisai
  • Natalia Andreeva, Manager of Clinical Research, Pharmacovigilance, Medical Projects, and Development at Ipsen
  • Tatiana Dunaeva, PhD, Head of Quality Assurance for Medical Research and Scientific Projects at Nizhpharm JSC
  • Anastasia Kozlova, Senior Manager of Medical Research and Scientific Support at Nizhpharm JSC

About the Forum:
The International Business Forum in Pharmaceuticals and Biotechnology in St. Petersburg, held at the ExpoForum Convention and Exhibition Center, included the conference "Dialogues on Clinical Research" on April 8–9, 2026. This event brought together representatives from pharmaceutical companies, research organizations, and professional associations, fostering collaboration and innovation in the field.